The relationships between the pathological hallmarks of Alzheimer’s disease, such as amyloid-beta (Aβ) deposition and Tau hyperphosphorylation, and glutamatergic transmission have mainly been studied in vitro [44, 45]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.